Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALACHITE INNOVATIONS, INC.

(MLCT)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about MALACHITE INNOVATIONS, INC.
11/15MALACHITE INNOVATIONS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
11/15Malachite Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Mon..
CI
10/12VITALITY BIOPHARMA : ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC - Form 8-K
PU
10/12VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Artic..
AQ
10/12VITALITY BIOPHARMA : Adopts New Name – Malachite Innovations, Inc.
GL
10/12Malachite Innovations, Inc. Announces Change of Corporate Headquarters
CI
10/12Malachite Innovations, Inc. Announces Fiscal Year Change
CI
10/12Malachite Innovations, Inc. has Changed its Ticker to MLCT from VBIO
CI
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY (F..
PU
09/02VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/23VITALITY BIOPHARMA : Enters into $5 million equity financing relationship with institution..
AQ
08/20VITALITY BIOPHARMA : ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTIT..
PU
08/20VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
08/20Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Insti..
GL
08/19Vitality Biopharma, Inc. announced that it expects to receive $5 million in funding
CI
08/13VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/13Vitality Biopharma, Inc. Reports Earnings Results for the First Quarter Ended June 30, ..
CI
08/12VITALITY BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
08/10VITALITY BIOPHARMA : FDA GRANTS VITALITY BIOPHARMA ORPHAN DRUG DESIGNATION FOR VBX-100 PRO..
PU
08/10VITALITY BIOPHARMA, INC. : Other Events (form 8-K)
AQ
08/10VITALITY BIOPHARMA : FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Pro..
AQ
06/22VITALITY BIOPHARMA : Letter from Michael Cavanaugh to the Company's Shareholders (Form 8-K..
PU
06/22VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16VITALITY BIOPHARMA : Letter from Weinberg and Co., P.A. to the Securities and Exchange Com..
PU
06/16VITALITY BIOPHARMA, INC. : Changes in Registrant's Certifying Accountant, Financial Statem..
AQ
05/19VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/19Vitality Biopharma, Inc. Reports Earnings Results for the Full Year Ended March 31, 202..
CI
05/19Vitality Biopharma, Inc. Auditor Raises 'Going Concern' Doubt
CI
03/12VITALITY BIOPHARMA, INC. : Other Events (form 8-K)
AQ
01/29VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
01/29Vitality Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended December ..
CI
2020VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Vitality Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended Septembe..
CI
2020VITALITY BIOPHARMA : Retains DelMorgan and Co. to Explore Strategic Alternatives
AQ
2020Vitality Biopharma Retains DelMorgan to Explore Strategic Alternatives
CI
2020VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Change in Directors..
AQ
2020Vitality Biopharma, Inc. Elects Brandon Zipp as Chief Science Officer
CI
2020VITALITY BIOPHARMA : Retains DelMorgan & Co. to Explore Strategic Alternatives
AQ
2020Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
GL
2020Vitality Biopharma, Inc. Reports Earnings Results for the First Quarter Ended June 30, ..
CI
2020VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Vitality Biopharma, Inc. Reports Earnings Results for the Full Year Ended March 31, 202..
CI
2020VITALITY BIOPHARMA, INC. : Other Events (form 8-K)
AQ
2020VITALITY BIOPHARMA : Board update
AQ
2020Vitality Biopharma, Inc. Announces Resignation of Anthony Maida from its Board of Direc..
CI
2020VITALITY BIOPHARMA : Board Update
AQ
2020VITALITY BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020VITALITY BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Vitality Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended December ..
CI
2019Vitality Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended Septembe..
CI
2019Vitality CBD Launch Across 265 Boots Stores
CI
2019Vitality Biopharma, Inc. Reports Earnings Results for the First Quarter Ended June 30, ..
CI
2019Vitality Biopharma, Inc. Reports Earnings Results for the Full Year Ended March 31, 201..
CI
2019Vitality Biopharma, Inc. Appoints Edward Feighan as Executive Chairman
CI
2019Vitality Biopharma, Inc. Announces Executive Changes
CI
2019Avtar Dhillon Resigns from Board of Directors of Vitality Biopharma, Inc
CI
2019Vitality Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended December ..
CI
2019Vitality Biopharma, Inc. Appoints Richard F. Celeste to Board
CI
2018Vitality Biopharma, Inc. Announces Board Changes
CI
2018Vitality Biopharma, Inc. acquired Addiction Clinic in Beverly Hills.
CI
2018Vitality Biopharma, Inc. announced that it has received $8.500008 million in funding
CI
2018Vitality Biopharma, Inc. announced that it expects to receive $8.500008 million in fund..
CI
2018Vitality Biopharma, Inc. announced that it has received $0.500001 million in funding
CI
2018Vitality Biopharma, Inc.'s THC Prodrug VBX-100 Demonstrates Positive Safety Results
CI
2018Vitality Biopharma, Inc. Auditor Raises 'Going Concern' Doubt
CI
2018Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D
CI
2018Vitality Biopharma, Inc. Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of T..
CI
2017Vitality Biopharma, Inc. announced that it has received $1.399998 million in funding
CI
2017Vitality Biopharma, Inc. announced that it expects to receive $1.4 million in funding
CI
2017Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharm..
CI
2017Vitality Biopharma, Inc. Announces Positive Results for Multiple Cannabinoid Drug Formu..
CI
2017Vitality Biopharma, Inc. announced that it has received $1 million in funding
CI
2017Vitality Biopharma, Inc. announced that it expects to receive $1 million in funding
CI
1  2Next